· Volume surge · RGC

Regencell Bioscience Holdings Ltd (RGC) sits in a 53.4% four-week drawdown

The latest weekly close left the healthcare name with weak momentum readings and an inactive trend state.

Weekly market chart concept for Regencell Bioscience with biotechnology lab equipment.

Regencell Bioscience Holdings Ltd (RGC) ended the latest week at 12.01 USD, a -36.2% one-week move, as the active-mover screen flagged turnover close to 2.0x its comparison pace.

The weekly price path over 52 weeks frames the move as weekly context, not intraday trading. Market Dynamics added pressure at -1.46, while Relative Strength stood at -52.1.

Volume confirmation was not uniform: weekly market data showed 891,377 shares, equal to 1.43x the 13-week average, below the active-mover flag but still elevated.